Merck & Co., Inc. Share Price

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 21:00:02 14/06/2024 BST 5-day change 1st Jan Change
129.5 USD +0.09% Intraday chart for Merck & Co., Inc. -0.91% +18.77%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 64.18B 5,060B Sales 2025 * 68.68B 5,415B Capitalization 328B 25,859B
Net income 2024 * 19.51B 1,538B Net income 2025 * 22.25B 1,754B EV / Sales 2024 * 5.4 x
Net Debt 2024 * 18.6B 1,467B Net Debt 2025 * 7.28B 574B EV / Sales 2025 * 4.88 x
P/E ratio 2024 *
16.7 x
P/E ratio 2025 *
14.5 x
Employees 71,000
Yield 2024 *
2.39%
Yield 2025 *
2.53%
Free-Float 70.77%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.09%
1 week-0.91%
Current month+3.14%
1 month-1.71%
3 months+6.55%
6 months+23.19%
Current year+18.77%
More quotes
1 week
128.59
Extreme 128.5901
132.71
1 month
122.70
Extreme 122.7
132.79
Current year
109.16
Extreme 109.16
133.10
1 year
99.14
Extreme 99.14
133.10
3 years
70.89
Extreme 70.89
133.10
5 years
65.25
Extreme 65.25
133.10
10 years
45.69
Extreme 45.69
133.10
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 31/03/14
Director of Finance/CFO 55 31/12/89
Chief Tech/Sci/R&D Officer 55 31/07/20
Members of the board TitleAgeSince
Director/Board Member 63 26/11/07
Director/Board Member 67 31/08/15
Director/Board Member 69 28/02/18
More insiders
Date Price Change Volume
14/06/24 129.5 +0.09% 7,338,462
13/06/24 129.4 -0.64% 5,004,226
12/06/24 130.2 -1.24% 5,821,965
11/06/24 131.8 +0.27% 11,453,195
10/06/24 131.5 +0.63% 6,033,808

Delayed Quote Nyse, June 14, 2024 at 09:00 pm

More quotes
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5 USD
Average target price
142.7 USD
Spread / Average Target
+10.20%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW